Citation: | GAO Chen-xi, CHEN Qing-yong. Systematic Review on the Efficacy of Atrial Fibrillation Screening Using Wearable Devices[J]. Chinese Journal of General Practice, 2022, 20(7): 1230-1234. doi: 10.16766/j.cnki.issn.1674-4152.002565 |
[1] |
CURRY S J, KRIST A H, OWENS D K, et al. Screening for atrial fibrillation with electrocardiography: US Preventive Services Task Force recommendation statement[J]. JAMA, 2018, 320(5): 478-484. doi: 10.1001/jama.2018.10321
|
[2] |
刘露, 刘晓宇. 全科医生在心房颤动综合管理中的作用[J]. 中华全科医学, 2021, 19(9): 1553-1556. doi: 10.16766/j.cnki.issn.1674-4152.002110
LIU L, LIU X Y. Role of general practitioners in the integrated management of atrial fibrillation[J]. Chin J General Practice, 2021, 19(9): 1553-1556. doi: 10.16766/j.cnki.issn.1674-4152.002110
|
[3] |
BIERSTEKER T E, SCHALIJ M J, TRESKES R W. Impact of mobile health devices for the detection of atrial fibrillation: Systematic review[J]. JMIR Mhealth Uhealth, 2021, 9(4): e26161. DOI: 10.2196/26161.
|
[4] |
MOHER D, LIBERATI A, TETZLAFF J, et al. Preferred reporting items for ssystematic reviews and meta-analyses: The PRISMA statement[J]. J Clin Epidemiol, 2009, 62(10): 1006-1012. doi: 10.1016/j.jclinepi.2009.06.005
|
[5] |
刘括, 孙殿钦, 廖星, 等. 随机对照试验偏倚风险评估工具2.0修订版解读[J]. 中国循证心血管医学杂志, 2019, 11(3): 284-291. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201903006.htm
LIU K, SUN D Q, LIAO X, et al. Interpretation of revised version 2.0 of the Risk of Bias Assessment Tool for Randomized Controlled Trials[J]. Chin J Evid Based Cardiovasc Med, 2019, 11(3): 284-291. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201903006.htm
|
[6] |
KAURA A, SZTRIHA L, CHAN F K, et al. Early prolonged ambulatory cardiac monitoring in stroke (EPACS): An open-label randomised controlled trial[J]. Eur J Med Res, 2019, 24(1): 25-34. doi: 10.1186/s40001-019-0383-8
|
[7] |
OKUBO Y, TOKUYAMA T, OKAMURA S, et al. Evaluation of the feasibility and efficacy of a novel device for screening silent atrial fibrillation (MYBEAT trial)[J]. Circ J, 2022, 86(2): 182-188. doi: 10.1253/circj.CJ-20-1061
|
[8] |
HA A C T, VERMA S, MAZER C D, et al. Effect of continuous electrocardiogram monitoring on detection of undiagnosed atrial fibrillation after hospitalization for cardiac surgery: A randomized clinical trial[J]. JAMA Netw Open, 2021, 4(8): e2121867. DOI: 10.1001/jamanetworkopen.2021.21867.
|
[9] |
STEINHUBL S R, WAALEN J, EDWARDS A M, et al. Effect of a home-based wearable continuous ecg monitoring patch on detection of undiagnosed atrial fibrillation: The mSToPS randomized clinical trial[J]. JAMA, 2018, 10(2): 146-155.
|
[10] |
GLADSTONE D J, WACHTER R, SCHMALSTIEG-BAHR K, et al. Screening for atrial fibrillation in the older population: A randomized clinical trial[J]. JAMA Cardiol, 2021, 6(5): 558-567. doi: 10.1001/jamacardio.2021.0038
|
[11] |
HALCOX J P J, WAREHAM K, CARDEW A, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: The REHEARSE-AF study[J]. Circulation, 2017, 136(19): 1784-1794. doi: 10.1161/CIRCULATIONAHA.117.030583
|
[12] |
KOH K T, LAW W C, ZAW W M, et al. Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: A multicentre randomized controlled trial[J]. Europace, 2021, 23(7): 1016-1023. doi: 10.1093/europace/euab036
|
[13] |
GOLDENTHAL I L, SCIACCA R R, RIGA T, et al. Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: IHEART results[J]. J Cardiovasc Electrophysiol, 2019, 30(11): 2220-2228. doi: 10.1111/jce.14160
|
[14] |
MANCINETTI M, SCHUKRAFT S, FAUCHERRE Y, et al. Handheld ECG tracking of in-hospital atrial fibrillation (HECTO-AF): A randomized controlled trial[J]. Front Cardiovasc Med, 2021, 8: 681890. DOI: 10.3389/fcvm.2021.681890.
|
[15] |
KAASENBROOD F, HOLLANDER M, DE BRUIJN S H, et al. Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: A cluster randomised controlled trial[J]. Br J Gen Pract, 2020, 70(695): e427-e433. doi: 10.3399/bjgp20X708161
|
[16] |
UITTENBOGAART S B, VERBIEST-VAN G N, LUCASSEN W A M, et al. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: Cluster randomised controlled trial[J]. BMJ, 2020, 370: m3208. DOI: 10.1136/bmj.m3208.
|
[17] |
QUER G, FREEDMAN B, STEINHUBL S R. Screening for atrial fibrillation: Predicted sensitivity of short, intermittent electrocardiogram recordings in an asymptomatic at-risk population[J]. Europace, 2020, 22(12): 1781-1787. doi: 10.1093/europace/euaa186
|